THE SMART TRICK OF ABBV-744 PRECLINICAL STUDIES AND RESULTS THAT NOBODY IS DISCUSSING

In Section A, individuals will receive unique doses and schedules of oral ABBV-744 pill to identify Harmless dosing regimen. Supplemental members are going to be enrolled within the identified monotherapy dosign routine. In Segment B, contributors will get oral ruxolitinib and ABBV-744 are going to be supplied as "incorporate-on" therapy. In Segmen